Korea UCB Co., Ltd. clinical trials
A country office of UCB S.A.
The registry lists 1 studies whose lead sponsor is Korea UCB Co., Ltd.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 20, 2015.
Registry sponsor names on this page
- Korea UCB Co., Ltd.1 study
Something wrong with this grouping? Tell us on the UCB S.A. page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All UCB S.A. studies →
- Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subjects With Newly or Recently Diagnosed Partial EpilepsyCompletedNCT01498822Phase 4
Sponsor listed in the registry: Korea UCB Co., Ltd.